www.biopharminternational.com Quality and Regulatory Sourcebook eBook March 2024 BioPharm International
®
23
Manufacturing
Cycle Assessment of Electronics. In Proceedings of
IEEE Conference on Technologies for Sustainability
(SusTech), Piscataway, NJ, 2014, pp. 22–29.
13. Donawa, M. Medical Device Clinical Investigations.
Whitepaper, 2006.
14. DIN EN ISO 14040:2006. Umweltmanagement—Öko-
bilanz—Grundsätze und Rahmenbedingungen (2021).
15. Goedkoop, M.; Oele, M.; Leijting, J.; Ponsioen, T.; Mei-
jer, E. Introduction to LCA with SimaPro; PRé Sustain-
ability B.V., 2016.
16. ISPE. End-Of-Life Management for Single-Use Prod-
ucts in Bioproduction Part 1. ispe.org, March 14, 2023.
17. ISPE. End-Of-Life Management for Single-Use
Products in Bioproduction Part 2. ispe.org, March
24, 2023.
18. USP. USP General Chapter <665>, Plastic Compo-
nents and Systems Used to Manufacture Pharma-
ceutical Drug Products and Biopharmaceutical Drug
Substances and Products. USP-NF (Rockville, Md.,
2022).
19. BioPhorum. Best Practices Guide for Evaluating
Leachables Risk from Polymeric SUS Used in Biophar-
maceutical Manufacturing (June 2018).
20. USP. USP General Chapter <1665>, Characterization
and Qualification of Plastic Components and Sys-
tems Used to Manufacture Pharmaceutical Drug
Products and Biopharmaceutical Drug Substances
and Products. USP-NF (Rockville, Md., 2023).
■
Ramesh Raju Mavuleti*,
rrajum@gmail.com, is head
of operations, Validation Services India;
Subhasis Banerjee, PhD,
is principal technical application expert,
Bioprocessing APAC; and
Tathagata Ray,
is consultant, Global Strategy Deployment;
all at Merck Life Sciences Pvt, Ltd.;
K. Vasantakumar Pai, PhD ,
is professor and chairman, PG Department
of studies & research in
Industrial Chemistry, Kuvempu University;
K. Sreedhara Ranganath Pai, PhD,
is professor, Department
of Pharmacology, Manipal Academy
of Higher Education; and
Somasundaram Gopalakrishnan,
is senior consultant, Global Biopharm
Center of Excellence, Merck Pte. Ltd.
*To whom all correspondence should be addressed.
Zara Bukhari, PhD
Student, Biochemistry
University of the Pacific
Stockton, California
John Gabrielson
Senior Vice-President, Biosimilars,
and Head of Business
JSR Life Sciences
The Biosimilars Landscape
This episode of the Drug Solutions podcast
gives an overview of the biosimilars market.
Industry experts discuss regulatory controls,
pricing pressure, the state of the healthcare
industry, and other factors affecting the uptake
of biosimilars in the market. Manufacturing
challenges as well as current and future needs
will also be discussed.
Pharmaceutical Technology presents the Drug
Solutions podcast, where the editors chat with
industry experts from across the pharmaceutical
and biopharmaceutical supply chain. Join us
as experts share insights into your biggest
questions—from the technologies, to strategies,
to regulations related to the development and
manufacture of drug products.
For more podcast
episodes, visit our website!
SCAN
ME
